Related Experiment Video
Updated: Aug 27, 2025

Cardiac Magnetic Resonance for the Evaluation of Suspected Cardiac Thrombus: Conventional and Emerging Techniques
Published on: June 11, 2019
Evidence-Based Recommendations: Management of Left Ventricular Thrombus Post-Acute Myocardial Infarction
Insights
Left ventricular thrombus (LVT) is a complication of myocardial infarction. Early treatment reduces LVT risk, but it remains significant, necessitating anticoagulation and antiplatelet therapies for prevention of embolism and death.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Left ventricular thrombus (LVT) is a potential complication following acute myocardial infarction (AMI).
- While early reperfusion has reduced LVT incidence, the risk of systemic embolism, stroke, and mortality persists.
- Current guidelines recommend dual antiplatelet and anticoagulation therapy for at least 3 months.
Purpose of the Study:
- To provide a comprehensive review of left ventricular thrombus (LVT).
- To discuss the pathophysiology, diagnostic methods, and management strategies for LVT.
Main Methods:
- Review of current literature on LVT following AMI.
- Analysis of diagnostic accuracy of imaging modalities like cardiac magnetic resonance and echocardiography.
- Evaluation of therapeutic approaches including anticoagulation and antiplatelet agents.
Main Results:
- Cardiac magnetic resonance offers the highest diagnostic accuracy for LVT detection.
- Echocardiography with contrast agents is also a valuable diagnostic tool.
- Direct-acting oral anticoagulants show promise in LVT management.
Conclusions:
- LVT remains a significant risk following AMI, despite advances in treatment.
- Accurate diagnosis and appropriate management, including novel anticoagulants, are crucial.
- Continued research is needed to optimize LVT prevention and treatment strategies.
Abstract:
One of the potential complications of acute myocardial infarction is left ventricular thrombus (LVT). The incidence of LVT following acute myocardial infarction has decreased dramatically with early invasive reperfusion techniques or fibrinolysis. However, the risk of LVT formation remains significant and is associated with an increased risk of systemic embolism, stroke, cardiovascular events, and even death. Current guidelines indicate that dual antiplatelet therapy and anticoagulation therapy for at least 3 months can reduce the risk of these events. While vitamin K antagonist is the preferred oral anticoagulant, there is growing evidence to support the use of direct-acting oral anticoagulants in LVT management. Cardiac magnetic resonance has shown the highest diagnostic accuracy for LVT assessment, followed by echocardiography with contrast agents. This article serves as a general review of the pathophysiology, diagnosis, and management of LVT.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Pulmonary Embolism III: Nursing Management
Myocarditis III: Medical Management
Acute Coronary Syndrome V: Nursing Management

